Clinical Trial Update: Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of pemetrexed in patients with ovarian cancer or primary peritoneal cancer after platinum-based chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Neoplasms, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED